Update on treatment of abdominal pain in irritable bowel syndrome: A narrative review.
Study Goal
The researchers aimed to evaluate the effectiveness of mindfulness as a behavioral therapy for global symptoms and pain relief in irritable bowel syndrome (IBS).
Results Summary
The study found that mindfulness, along with other behavioral therapies, demonstrated only modest benefit in improving global IBS symptoms and pain relief. Current evidence suggests limited efficacy compared to other interventions.
Population
Patients with irritable bowel syndrome (IBS).
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
medications | no change | global IBS symptoms and pain relief | patients with irritable bowel syndrome (IBS) | modest benefit | demonstrates only modest benefit | #1 |
dietary interventions including low fermentable oligosaccharides, disaccharides, and monosaccharides and polyols (FODMAP) diet | no change | global IBS symptoms and pain relief | patients with irritable bowel syndrome (IBS) | modest benefit | demonstrates only modest benefit | #2 |
fecal microbial transplantation (FMT) | no change | global IBS symptoms and pain relief | patients with irritable bowel syndrome (IBS) | modest benefit | demonstrates only modest benefit | #3 |
electrical approaches | no change | global IBS symptoms and pain relief | patients with irritable bowel syndrome (IBS) | modest benefit | demonstrates only modest benefit | #4 |
behavioral therapies including cognitive behavioral therapy (CBT), gut-directed hypnotherapy (GDH), mindfulness, and open-label placebo | no change | global IBS symptoms and pain relief | patients with irritable bowel syndrome (IBS) | modest benefit | demonstrates only modest benefit | #5 |
The objectives of this narrative review are to update readers on the current state-of-the-art regarding diverse approaches for the treatment of pain, global symptoms, or adequate relief in irritable bowel syndrome (IBS). The article appraises medications, dietary interventions including low fermentable oligosaccharides, disaccharides, and monosaccharides and polyols (FODMAP) diet, fecal microbial transplantation (FMT), electrical approaches, and behavioral therapies including cognitive behavioral therapy (CBT), gut-directed hypnotherapy (GDH), mindfulness, and open-label placebo. Current evidence demonstrates only modest benefit in global IBS symptoms and pain relief. A future approach that identifies pathophysiological mechanisms of IBS through validated biomarkers has the potential to individualize treatment of patients rather than sequential therapeutic trial and error approaches.